Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis

Chikahide Hori, Masahiro Hiraoka, Norishige Yoshikawa, Kazuo Tsuzuki, Yoshiyuki Yoshida, Kazuo Yoshioka, Kazuo Fujisawa, Hirokazu Tsukahara, Yusei Ohshima, Mitsufumi Mayumi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: There is little information on the significance of angiotensin-converting enzyme (ACE) genotypes and medical treatments in children with primary focal segmental glomerulosclerosis (FSGS). Methods: A multicenter retrospective study was performed on the role of ACE genotypes and medical treatments in 43 Japanese children with FSGS (20 males and 23 females), including 17 children who progressed to end-stage renal failure during the mean observation period of 6.9 ± (SD) 5.0 years. Results: The incidence of the D allele of the ACE gene was higher in the whole group of 43 children with FSGS and in a subgroup of 28 steroid-resistant FSGS children (p <0.05) than in the 130 children of the healthy control group (0.48, 0.48, and 0.33, respectively). ACE genotypes did not affect renal survival in the whole FSGS group nor in the steroid-resistant subgroup. Among the 28 steroid-resistant children, treatment with ciclosporin was effective in delaying the development of end-stage renal failure (p = 0.044), independently of other treatment regimens. Conclusion: The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes.

Original languageEnglish
Pages (from-to)313-319
Number of pages7
JournalNephron
Volume88
Issue number4
DOIs
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Focal Segmental Glomerulosclerosis
Peptidyl-Dipeptidase A
Genotype
Steroids
Therapeutics
Cyclosporine
Chronic Kidney Failure
Alleles
Genes
Multicenter Studies
Retrospective Studies
Observation
Kidney
Control Groups
Incidence

Keywords

  • Angiotensin-converting enzyme
  • Ciclosporin
  • Glomerulosclerosis, focal
  • Nephrotic syndrome
  • Polymorphism (genetics)

ASJC Scopus subject areas

  • Nephrology

Cite this

Hori, C., Hiraoka, M., Yoshikawa, N., Tsuzuki, K., Yoshida, Y., Yoshioka, K., ... Mayumi, M. (2001). Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis. Nephron, 88(4), 313-319. https://doi.org/10.1159/000046014

Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis. / Hori, Chikahide; Hiraoka, Masahiro; Yoshikawa, Norishige; Tsuzuki, Kazuo; Yoshida, Yoshiyuki; Yoshioka, Kazuo; Fujisawa, Kazuo; Tsukahara, Hirokazu; Ohshima, Yusei; Mayumi, Mitsufumi.

In: Nephron, Vol. 88, No. 4, 2001, p. 313-319.

Research output: Contribution to journalArticle

Hori, C, Hiraoka, M, Yoshikawa, N, Tsuzuki, K, Yoshida, Y, Yoshioka, K, Fujisawa, K, Tsukahara, H, Ohshima, Y & Mayumi, M 2001, 'Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis', Nephron, vol. 88, no. 4, pp. 313-319. https://doi.org/10.1159/000046014
Hori C, Hiraoka M, Yoshikawa N, Tsuzuki K, Yoshida Y, Yoshioka K et al. Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis. Nephron. 2001;88(4):313-319. https://doi.org/10.1159/000046014
Hori, Chikahide ; Hiraoka, Masahiro ; Yoshikawa, Norishige ; Tsuzuki, Kazuo ; Yoshida, Yoshiyuki ; Yoshioka, Kazuo ; Fujisawa, Kazuo ; Tsukahara, Hirokazu ; Ohshima, Yusei ; Mayumi, Mitsufumi. / Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis. In: Nephron. 2001 ; Vol. 88, No. 4. pp. 313-319.
@article{2af13d423dbd46809d5ced8ef632bfec,
title = "Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis",
abstract = "Background: There is little information on the significance of angiotensin-converting enzyme (ACE) genotypes and medical treatments in children with primary focal segmental glomerulosclerosis (FSGS). Methods: A multicenter retrospective study was performed on the role of ACE genotypes and medical treatments in 43 Japanese children with FSGS (20 males and 23 females), including 17 children who progressed to end-stage renal failure during the mean observation period of 6.9 ± (SD) 5.0 years. Results: The incidence of the D allele of the ACE gene was higher in the whole group of 43 children with FSGS and in a subgroup of 28 steroid-resistant FSGS children (p <0.05) than in the 130 children of the healthy control group (0.48, 0.48, and 0.33, respectively). ACE genotypes did not affect renal survival in the whole FSGS group nor in the steroid-resistant subgroup. Among the 28 steroid-resistant children, treatment with ciclosporin was effective in delaying the development of end-stage renal failure (p = 0.044), independently of other treatment regimens. Conclusion: The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes.",
keywords = "Angiotensin-converting enzyme, Ciclosporin, Glomerulosclerosis, focal, Nephrotic syndrome, Polymorphism (genetics)",
author = "Chikahide Hori and Masahiro Hiraoka and Norishige Yoshikawa and Kazuo Tsuzuki and Yoshiyuki Yoshida and Kazuo Yoshioka and Kazuo Fujisawa and Hirokazu Tsukahara and Yusei Ohshima and Mitsufumi Mayumi",
year = "2001",
doi = "10.1159/000046014",
language = "English",
volume = "88",
pages = "313--319",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis

AU - Hori, Chikahide

AU - Hiraoka, Masahiro

AU - Yoshikawa, Norishige

AU - Tsuzuki, Kazuo

AU - Yoshida, Yoshiyuki

AU - Yoshioka, Kazuo

AU - Fujisawa, Kazuo

AU - Tsukahara, Hirokazu

AU - Ohshima, Yusei

AU - Mayumi, Mitsufumi

PY - 2001

Y1 - 2001

N2 - Background: There is little information on the significance of angiotensin-converting enzyme (ACE) genotypes and medical treatments in children with primary focal segmental glomerulosclerosis (FSGS). Methods: A multicenter retrospective study was performed on the role of ACE genotypes and medical treatments in 43 Japanese children with FSGS (20 males and 23 females), including 17 children who progressed to end-stage renal failure during the mean observation period of 6.9 ± (SD) 5.0 years. Results: The incidence of the D allele of the ACE gene was higher in the whole group of 43 children with FSGS and in a subgroup of 28 steroid-resistant FSGS children (p <0.05) than in the 130 children of the healthy control group (0.48, 0.48, and 0.33, respectively). ACE genotypes did not affect renal survival in the whole FSGS group nor in the steroid-resistant subgroup. Among the 28 steroid-resistant children, treatment with ciclosporin was effective in delaying the development of end-stage renal failure (p = 0.044), independently of other treatment regimens. Conclusion: The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes.

AB - Background: There is little information on the significance of angiotensin-converting enzyme (ACE) genotypes and medical treatments in children with primary focal segmental glomerulosclerosis (FSGS). Methods: A multicenter retrospective study was performed on the role of ACE genotypes and medical treatments in 43 Japanese children with FSGS (20 males and 23 females), including 17 children who progressed to end-stage renal failure during the mean observation period of 6.9 ± (SD) 5.0 years. Results: The incidence of the D allele of the ACE gene was higher in the whole group of 43 children with FSGS and in a subgroup of 28 steroid-resistant FSGS children (p <0.05) than in the 130 children of the healthy control group (0.48, 0.48, and 0.33, respectively). ACE genotypes did not affect renal survival in the whole FSGS group nor in the steroid-resistant subgroup. Among the 28 steroid-resistant children, treatment with ciclosporin was effective in delaying the development of end-stage renal failure (p = 0.044), independently of other treatment regimens. Conclusion: The present study of Japanese children with FSGS showed that the D allele of the ACE gene is associated with the development of FSGS, but not associated with the progression of FSGS which was greatly ameliorated with ciclosporin, irrespective of ACE genotypes.

KW - Angiotensin-converting enzyme

KW - Ciclosporin

KW - Glomerulosclerosis, focal

KW - Nephrotic syndrome

KW - Polymorphism (genetics)

UR - http://www.scopus.com/inward/record.url?scp=17844369956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17844369956&partnerID=8YFLogxK

U2 - 10.1159/000046014

DO - 10.1159/000046014

M3 - Article

C2 - 11474225

AN - SCOPUS:17844369956

VL - 88

SP - 313

EP - 319

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

IS - 4

ER -